Cargando…
Genetically modified human umbilical cord blood cells as a promising strategy for treatment of spinal cord injury
Autores principales: | Mukhamedshina, Yana O., Rizvanov, Albert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090841/ https://www.ncbi.nlm.nih.gov/pubmed/27857742 http://dx.doi.org/10.4103/1673-5374.191213 |
Ejemplares similares
-
Human Umbilical Cord Blood Cell Transplantation in Neuroregenerative Strategies
por: Galieva, Luisa R., et al.
Publicado: (2017) -
Influence of Genetically Modified Human Umbilical Cord Blood Mononuclear Cells on the Expression of Schwann Cell Molecular Determinants in Spinal Cord Injury
por: Galieva, L. R., et al.
Publicado: (2018) -
Assessment of Glial Scar, Tissue Sparing, Behavioral Recovery and Axonal Regeneration following Acute Transplantation of Genetically Modified Human Umbilical Cord Blood Cells in a Rat Model of Spinal Cord Contusion
por: Mukhamedshina, Yana O., et al.
Publicado: (2016) -
Different Approaches to Modulation of Microglia Phenotypes After Spinal Cord Injury
por: Akhmetzyanova, Elvira, et al.
Publicado: (2019) -
Mesenchymal stem cells and the neuronal microenvironment in the area of spinal cord injury
por: Mukhamedshina, Yana O., et al.
Publicado: (2019)